Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer

被引:9
|
作者
Meng, Hui [1 ]
Nan, Manman [1 ]
Li, Yizhen [1 ]
Ding, Yi [1 ]
Yin, Yuhui [1 ]
Zhang, Mingzhi [2 ]
机构
[1] Zhengzhou Univ, Dept Pathol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[2] Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
来源
关键词
CRISPR tools; genome editing; colorectal carcinoma; Genetic tool; basic research; EPITHELIAL-MESENCHYMAL TRANSITION; COLORECTAL-CANCER; CELL-SURVIVAL; GENOMIC DNA; IN-VITRO; BINDING; PROLIFERATION; TARGET; RNA; OVEREXPRESSION;
D O I
10.3389/fendo.2023.1148412
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Colon cancer is the fourth leading cause of cancer death worldwide, and its progression is accompanied by a complex array of genetic variations. CRISPR/Cas9 can identify new drug-resistant or sensitive mutations in colon cancer, and can use gene editing technology to develop new therapeutic targets and provide personalized treatments, thereby significantly improving the treatment of colon cancer patients. CRISPR/Cas9 systems are driving advances in biotechnology. RNA-directed Cas enzymes have accelerated the pace of basic research and led to clinical breakthroughs. This article reviews the rapid development of CRISPR/Cas in colon cancer, from gene editing to transcription regulation, gene knockout, genome-wide CRISPR tools, therapeutic targets, stem cell genomics, immunotherapy, metabolism-related genes and inflammatory bowel disease. In addition, the limitations and future development of CRISPR/Cas9 in colon cancer studies are reviewed. In conclusion, this article reviews the application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer.
引用
收藏
页数:21
相关论文
共 50 条
  • [1] Gene editing for the treatment of lung cancer (CRISPR-Cas9)
    Castillo, Andres
    COLOMBIA MEDICA, 2016, 47 (04): : 178 - 180
  • [2] Review of applications of CRISPR-Cas9 gene-editing technology in cancer research
    Zhao, Ziyi
    Li, Chenxi
    Tong, Fei
    Deng, Jingkuang
    Huang, Guofu
    Sang, Yi
    BIOLOGICAL PROCEDURES ONLINE, 2021, 23 (01)
  • [3] Review of applications of CRISPR-Cas9 gene-editing technology in cancer research
    Ziyi Zhao
    Chenxi Li
    Fei Tong
    Jingkuang Deng
    Guofu Huang
    Yi Sang
    Biological Procedures Online, 23
  • [4] Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer
    Zhang, Huimin
    Qin, Chunhong
    An, Changming
    Zheng, Xiwang
    Wen, Shuxin
    Chen, Wenjie
    Liu, Xianfang
    Lv, Zhenghua
    Yang, Pingchang
    Xu, Wei
    Gao, Wei
    Wu, Yongyan
    MOLECULAR CANCER, 2021, 20 (01)
  • [5] Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer
    Huimin Zhang
    Chunhong Qin
    Changming An
    Xiwang Zheng
    Shuxin Wen
    Wenjie Chen
    Xianfang Liu
    Zhenghua Lv
    Pingchang Yang
    Wei Xu
    Wei Gao
    Yongyan Wu
    Molecular Cancer, 20
  • [6] Application of CRISPR-Cas9 gene editing to treat HBV
    Yan, Kun
    Feng, Jiangpeng
    Xiong, Yong
    Chen, Yu
    CHINESE SCIENCE BULLETIN-CHINESE, 2019, 64 (30): : 3142 - 3150
  • [7] CRISPR-Cas9: A Potent Gene-editing Tool for the Treatment of Cancer
    Mishra, Gauri
    Srivastava, Kamakshi
    Rais, Juhi
    Dixit, Manish
    Singh, Vandana Kumari
    Mishra, Lokesh Chandra
    CURRENT MOLECULAR MEDICINE, 2024, 24 (02) : 191 - 204
  • [8] CRISPR-Cas9: from Genome Editing to Cancer Research
    Chen, Si
    Sun, Heng
    Miao, Kai
    Deng, Chu-Xia
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2016, 12 (12): : 1427 - 1436
  • [9] Treatment by CRISPR-Cas9 Gene Editing - A Proof of Principle
    Malech, Harry L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (03): : 286 - 287
  • [10] Application of CRISPR-Cas9 technology in diabetes research
    Lotfi, Malihe
    Butler, Alexandra E.
    Sukhorukov, Vasily N.
    Sahebkar, Amirhossein
    DIABETIC MEDICINE, 2024, 41 (01)